Relation between body iron status and cardiovascular risk factors in patients with cardiovascular disease

International Journal of Preventive Medicine

Volumn 4, Issue 8, 2013, Pages 911-916

  Eftekhari, Mohammad Hassan ^a   Mozaffari Khosravi, Hassan ^b   Shidfar, Farzad ^c   Zamani, Atefeh ^d  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Shaheed Sadooghi University of Medical Sciences   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C reactive protein; Cardiovascular disease; Ferritin

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY IRON STATUS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; FEMALE; HEALTH STATUS; HUMAN; IRAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLISM; WAIST CIRCUMFERENCE;

EID: 84884144379     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Rehema A, Zilmer M, Zilmer K, Kullisaar T, Vihalemm T. Could long-term alimentary iron overload have an impact on the parameters of oxidative stress? A study on the basis of a village in southern Estonia. Ann Nutr Metab 1998;42:40-3.
2. Glei M, Latunde-Dada GO, Klinder A, Becker TW, Hermann U, Voigt K, et al. Iron-overload induces oxidative DNA damage in the human colon carcinoma cell line HT29 clone 19A. Mutat Res 2002;519:151-61.
3. Fischer JG, Glauert HP, Yin T, Sweeney-Reeves ML, Larmonier N, Black MC. Moderate iron overload enhances lipid peroxidation in livers of rats, but does not affect NF-kappaB activation induced by the peroxisome proliferator, Wy-14, 643. J Nutr 2002;132:2525-31.
4. Day SM, Duquaine D, Mundada LV, Menon RG, Khan BV, Rajagopalan S, et al. Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation 2003;107:2601-6.
5. Brown SM, Bicknell R. Hypoxia and oxidative stress in breast cancer. Oxidative stress: Its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res 2001;3:323-7.
6. Nunez MT, Tapia VS, Toyokuni S, Okada S. Iron-induced oxidative damage in colon carcinoma (Caco-2) cells. Free Rad Res 2001;34:57-68.
7. Esterbauer H, Wag G, Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull 1993;49:566-76.
8. Tuomainen TP, Punnonen K, Nyyssönen K, Salonen JT. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 1998;97:1461-6.
9. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-92.
10. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, et al. Autoantibody against the major oxysterols in human circulation carotid atherosclerosis. Lancet 1992;339:883-7.
11. Smith LL, Johnson BH. Biological activities of oxysterols. Free Radic Biol Med 1989;7:285-332.
12. Brown AJ, Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999;142:1-28.
13. Russell DW. Oxysterol biosynthetic enzymes. Biochim Biophys Acta 2000;1529:126-35.
14. Meaney S, Hassan M, Sakinis A, Lütjohann D, von Bergmann D, Wennmalm A, et al. Evidence that the major oxysterols in human circulation originate from distinct pools of cholesterol: A stable isotope study. J Lipid Res 2001;42:70-8.
15. Salonen JT. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res 1988;20:46-50.
16. MONICAManual, Part IV, Event Registration. Available from: http://wwwktl.fi/publications/monica/manual/index.htm [Last accessed on 2012 Oct 30].
17. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-11.
18. Salonen JT, Nyyssönen K, Salonen R. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;331:1159.
19. Baer DM, Tekawa IS, Hurley LB. Iron stores are not associated with acute myocardial infarction. Circulation 1994;89:2915-8.
20. Sempos CT, Looker AC, Gillum RF, Makuc DM. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;330:1119-24.
21. Liao Y, Cooper RS, McGee DL. Iron status and coronary heart disease: Negative findings from the NHANES I epidemiologic follow-up study. Am J Epidemiol 1994;139:704-12.
22. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97:2007-11.
23. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis. JAMA 2001;285:2481-5.
24. Friiedewald WT, Levi RI, Fredrickson DS. Estimation of the concentration of low density lipoproteins cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1972;18:499-502.
25. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981;1:1293-4.
26. Mainous AG, Wells BJ, Everett CJ, Gill JM, King DA. Association of ferritiin and lipids with, C-reactive protein. Am J Card 2004;93:559-62.
27. Tuomainen TP, Salonen R, Nyyssönen K, Salonen JT. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. BMJ 1997;314:793-4.
28. Zegrean M. Association of body iron stores with development of cardiovascular disease in the adult population: A systematic review of the literature. Can J Cardiovasc Nurs 2009;19:26-32.
29. Bullo M, Garcia-Lorda P, Megias I, Salas-Salvado J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 2003;85:3338-42.
30. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance and endothelial dysfunction: A potential role for cytokines originating from adipose tissue. Int J Obes 1999;19:972-8.
31. Santos AC, Lopes C, Guimaraes JT, Barros H. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. Int J Obes 2005;29:1452-6.
32. Shemesh T, Rowley KG, Jenkins A, Brimblecombe J, Best JD, O'Dea K. Differential association of C-reactive protein with adiposity in men and women in an Aboriginal community in northeast Arnhem Land of Australia. Int J Obes 2007;31:103-8.